shareholdersunite.com

Opportunities in smallcaps

shareholdersunite.com header image 2

EyePoint Pharmaceuticals Is Eyeing 2 Big Market Opportunities

August 31st, 2019 · No Comments

  • EyePoint Pharmaceuticals has just introduced two new treatments, YUTIQ and DEXYCU, both involve the slow release of steroids to prevent eye infections.
  • Most of the elements for successful market penetration are already in place, and these markets are substantial.
  • Depending on the speed of growth, the company might need another financing.
  • While speculative, it’s a high-risk, high-reward situation.

Source: EyePoint Pharmaceuticals Is Eyeing 2 Big Market Opportunities – EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) | Seeking Alpha

Tags: EYPT